These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30527272)

  • 21. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.
    Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; ; Engberg G; Erhardt S
    Acta Psychiatr Scand; 2018 Nov; 138(5):432-440. PubMed ID: 30132802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D; Brouwer MC; Daha MR; Hack CE
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk.
    Zhang T; Zeng J; Ye J; Gao Y; Hu Y; Xu L; Wei Y; Tang X; Liu H; Chen T; Li C; Wan C; Wang J
    Transl Psychiatry; 2023 Jan; 13(1):9. PubMed ID: 36631451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.
    Zeni-Graiff M; Rizzo LB; Mansur RB; Maurya PK; Sethi S; Cunha GR; Asevedo E; Pan P; Zugman A; Yamagata AS; Higuchi C; Bressan RA; Gadelha A; Brietzke E
    Schizophr Res; 2016 Oct; 176(2-3):191-195. PubMed ID: 27424266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.
    Thompson A; Papas A; Bartholomeusz C; Allott K; Amminger GP; Nelson B; Wood S; Yung A
    Schizophr Res; 2012 Nov; 141(2-3):204-9. PubMed ID: 22959742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy.
    Santos Sória Ld; Moura Gubert Cd; Ceresér KM; Gama CS; Kapczinski F
    Braz J Psychiatry; 2012 Mar; 34(1):119-20. PubMed ID: 22392401
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.
    Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML
    J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in first-episode psychosis and in people at ultra-high risk.
    Cocchi A; Lora A; Meneghelli A; La Greca E; Pisano A; Cascio MT; Preti A; ;
    Psychiatry Res; 2014 Feb; 215(2):314-22. PubMed ID: 24355686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulcogyral pattern and sulcal count of the orbitofrontal cortex in individuals at ultra high risk for psychosis.
    Lavoie S; Bartholomeuz CF; Nelson B; Lin A; McGorry PD; Velakoulis D; Whittle SL; Yung AR; Pantelis C; Wood SJ
    Schizophr Res; 2014 Apr; 154(1-3):93-9. PubMed ID: 24630136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment.
    El-Fatah Fahmy Hanno A; Mohiedeen KM; Deghedy A; Sayed R
    Arab J Gastroenterol; 2014 Jun; 15(2):58-62. PubMed ID: 25097047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood gene expression of acute phase proteins in people with first episode psychosis.
    Yee JY; Nurjono M; Ng WY; Teo SR; Lee TS; Lee J
    Brain Behav Immun; 2017 Oct; 65():337-341. PubMed ID: 28627459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities in chemokine levels in schizophrenia and their clinical correlates.
    Hong S; Lee EE; Martin AS; Soontornniyomkij B; Soontornniyomkij V; Achim CL; Reuter C; Irwin MR; Eyler LT; Jeste DV
    Schizophr Res; 2017 Mar; 181():63-69. PubMed ID: 27650194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels.
    Akcan U; Karabulut S; İsmail Küçükali C; Çakır S; Tüzün E
    Acta Neuropsychiatr; 2018 Apr; 30(2):70-78. PubMed ID: 28399943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.